MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery
Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The objective of our research is to determine whether treatment with magnesium will reduce
the incidence of atrial fibrillation in patients undergoing cardiac surgery. Several small
studies of magnesium have already been conducted, but these studies were small and the
results conflicting. A large, well-conducted study of magnesium treatment is required to
definitively determine whether magnesium is effective in preventing this common complication
after surgery. In addition, our study will include patients undergoing valvular surgery, a
group previously excluded from research despite the fact that they are at increased risk of
atrial fibrillation.